Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Maria Brouch"'
Autor:
Beata Holkova, Hang Quach, Christoph M. Ahlers, Nicola Jackson, Brandon E. Kremer, Niels W.C.J. van de Donk, Katja Weisel, Maria Brouch, Suzanne Trudel, Ellie Im, Sofia Paul, Paul G. Richardson, Rocio Montes de Oca, Shinta Cheng, Paula Rodriguez Otero, Geraldine Ferron-Brady, Kevin W. Song, L Smith, Monique C. Minnema, Ajay K. Nooka, David Routledge, Ira Gupta, Natalie S. Callander, Nahi Hareth
Publikováno v:
Future oncology (London, England). 17(16)
Belantamab mafodotin (belamaf) is a BCMA-targeted antibody–drug conjugate recently approved as monotherapy for adults with relapsed/refractory multiple myeloma who have received ≥4 prior therapies. Belamaf binds to BCMA and eliminates myeloma cel
Autor:
Anne Yeakey, Paul G. Richardson, Chris Shelton, David Routledge, Ajay K. Nooka, Hareth Nahi, Suzanne Trudel, Hang Quach, Brandon E. Kremer, Kevin W. Song, Rocio Montes de Oca, Elaine M. Paul, Josephine Khan, Paula Rodriguez-Otero, Beata Holkova, Sofia Paul, Maria Brouch, Geraldine Ferron-Brady, Ira Gupta, Ellie Im, L. Mary Smith, Christoph M. Ahlers
Publikováno v:
Blood. 136:1-2
Introduction: Single-agent belamaf (GSK2857916), a B-cell maturation antigen-targeting antibody-drug conjugate, induced deep and durable responses in patients with RRMM, with a manageable safety profile with 13 months of follow-up (DREAMM-2; NCT03525